Grants Awarded



Click on any project title for a more detailed description of the project. For more information about any of these awards (e.g., PI contact information or associated publications), please use the corresponding project number to search for information at the NIH Reporter website. Consistent with NIH policy, abstracts are not available for projects receiving their first award within the past year, so descriptions provided below are from the NCI program director.

New awards will be posted as they are issued.

Year Award Type Project # RFA # PI/Project Leader Institution Title Statussort descending
2003 R33 PAR-01-106 RONINSON, IGOR B ORDWAY RESEARCH INSTITUTE, INC. FUNCTION-BASED SELECTION OF TARGET GENES IN TUMOR CELLS Complete
2007 R21 RFA-CA-07-001 DING, ZHIYONG UT MD ANDERSON CANCER CTR EFFECTIVE MAMMALIAN TWO HYBRID SCREENING APPROACH Complete
2009 R33 RFA-CA-08-008 BEEBE, DAVID J UNIVERSITY OF WISCONSIN-MADISON MICROCHANNEL CELL-BASED ASSAYS TO ENABLE CANCER RESEARCH Complete
2013 R33 RFA-CA-12-003 FURDUI, CRISTINA MARIA WAKE FOREST UNIVERSITY HEALTH SCIENCES NEW REAGENTS FOR TRACKING PROTEIN OXIDATION IN CELLS BY MS AND IMAGING METHODS Complete
2016 R43 PAR-13-327 LIM, MARK AMBERGEN, INC Photocleavage Technology for Improved Serum-based Multi-Biomarker Cancer Assays Complete
2000 R41 PAR-98-066 LIFSHITZ, NADIA BIOPHOTONICS CORPORATION MONOLITHIC MULTI-CAPILLARY ARRAYS TO SEQUENCE DNA Complete
2002 R43 PAR-01-105 BECKER, CHRISTOPHER SURROMED, INC. AFFINITY MASS TAGS FOR DIFFERENTIAL PHENOTYPING Complete
2006 R21 RFA-CA-06-003 MEYER, TOBIAS STANFORD UNIVERSITY DISSECTION OF THE MODULAR STRUCTURE OF CANCER SIGNALING SYSTEMS Complete
2009 R21 RFA-CA-08-006 LESSNICK, STEPHEN L. UNIVERSITY OF UTAH ANTIBODY-BASED DETECTION OF TRANSLOCATIONS IN PEDIATRIC CANCER Complete
2012 R21 RFA-CA-12-002 TAO, NONGJIAN ARIZONA STATE UNIVERSITY-TEMPE CAMPUS CHARGE SENSITIVE OPTICAL DETECTION FOR HIGH THROUGHPUT STUDY OF SMALL MOLECULES Complete
2016 R21 RFA-CA-15-002 BURGETT, ANTHONY WG UNIVERSITY OF OKLAHOMA NORMAN MASS SPECTROMETRY DETECTION OF DRUGS IN SINGLE BLADDER CANCER CELLS FROM PATIENTS Complete
2019 R21 RFA-CA-18-002 MONTAGNA, CRISTINA ALBERT EINSTEIN COLLEGE OF MEDICINE Development of a high-resolution mapping platform for HPV DNA integration in premalignant lesions Complete
2019 R33 RFA-CA-18-003 KETTENBACH, ARMINJA NADINE DARTMOUTH COLLEGE Activity based profiling of Phosphoprotein phosphatases in cancer using mass spectrometry-based proteomics Complete
2000 R21 PAR-99-100 WEISSMAN, SHERMAN MORTON YALE UNIVERSITY DISPLAY METHODS FOR SURVEYING MUTATIONS Complete
2002 R21 PAR-99-102 MEHTA, ANAND S THOMAS JEFFERSON UNIVERSITY IDENTIFICATION OF SERUM GLYCOSYLATION MARKERS OF HCC Complete
2005 R21 RFA-CA-05-003 LIZARDI, PAUL M. YALE UNIVERSITY GLOBAL DNA METHYLATION PROFILES OF HEAD AND NECK CANCERS Complete
2008 R21 RFA-CA-07-035 KRON, STEPHEN J UNIVERSITY OF CHICAGO MALDI IMAGING OF CANCER SIGNALING SIGNATURES Complete
2011 R21 RFA-CA-10-005 DECAPRIO, ANTHONY P FLORIDA INTERNATIONAL UNIVERSITY PLATFORM FOR HIGH-THROUGHPUT ANALYSIS OF PROTEIN ADDUCTS FOR CARCINOGEN EXPOSURE Complete
2015 R21 RFA-CA-14-005 PENNO, MARGARET B JOHNS HOPKINS UNIVERSITY PEDIATRIC CANCER SALVIA BIOREPOSITORY Complete
2018 R33 RFA-CA-17-011 LU, JUN YALE UNIVERSITY CRISPR-based Enhanced Molecular Chipper Technology for Identifying Functional Noncoding Elements in Cancer Complete
1999 R43 PAR-98-066 TS'O, PAUL O. P. CCC DIAGNOSTICS, LLC ISOLATION AND PROFILING OF CIRCULATING PC CELLS IN BLOOD Complete
2001 R43 PAR-99-101 JOHNSON, PAUL H EPIGENX PHARMACEUTICALS WHOLE GENOME METHYLATION ASSAY Complete
2004 R43 PAR-01-105 PARIS, MARK J VACCINEX, INC. FUNCTIONAL IDENTIFICATION OF CANCER REGULATORS Complete
2007 R33 RFA-CA-07-002 MOORE, PATRICK S. UNIVERSITY OF PITTSBURGH AT PITTSBURGH EMERGING TECHNOLOGIES APPLIED TO THE DISCOVERY OF HUMAN TUMOR VIRUSES Complete
2010 R21 RFA-CA-09-008 SOUSA, RUI J. UNIVERSITY OF TEXAS HLTH SCIENCE CENTER DEVELOPMENT OF IMAGING REAGENTS TO MONITOR GTP LEVELS AND GTP/GDP RATIOS IN VIVO Complete
2014 R33 RFA-CA-13-002 FEDERSPIEL, MARK J MAYO CLINIC ROCHESTER VALIDATING TECHNOLOGY TO OPTIMIZE ANTIBODY AFFINITY FOR TARGETING THERAPEUTICS Complete
2017 R33 RFA-CA-16-002 KLEIN, ALLON MOSHE HARVARD MEDICAL SCHOOL Droplet microfluidic technology for single cell cancer genomics Complete
2001 R33 PAR-98-067 MELDRUM, DEIRDRE R. UNIVERSITY OF WASHINGTON AUTOMATED MINIMAL RESIDUAL DISEASE QUANTIFICATION Complete
2003 R41 PAR-01-105 SANTANGELO, PHILIP J VIVONETICS, INC. IN VIVO GENE EXPRESSION IMAGING FOR CANCER ANALYSIS Complete
2007 R21 RFA-CA-07-001 BIEBERICH, CHARLES J. UNIVERSITY OF MARYLAND BALT CO CAMPUS AN INNOVATIVE APPROACH FOR PROFILING PROTEIN KINASE SUBSTRATES Complete
2009 R33 RFA-CA-08-008 SHI, HUIDONG GEORGIA REGENTS UNIVERSITY APPLICATION OF 454 SEQUENCING TO CANCER EPIGENOMICS Complete
2013 R33 RFA-CA-12-003 BAILEY, RYAN C UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN MESO-PLEX MIRNA AND PROTEIN PROFILING FOR CANCER DIAGNOSTICS USING CHIP-INTEGRATE Complete
2016 R43 PAR-13-327 KING, JEFFREY S VIROGENOMICS BIODEVELOPMENT, INC. Sensitive Single Cell PhosphoCount Platform for Drug-Insensitive Cell Detection and Combination Drug Screening for Leukemia Complete
2000 R43 PAR-99-101 BUTT, TAUSEEF R. LIFESENSORS, INC. LIVESENSORS FOR MOLECULAR PROFILING IN PROSTATE CANCER Complete
2002 R43 PAR-01-105 STRAUME, TORE GENMETRIX, LLC ASSAY FOR DETECTION OF CANCER CHROMOSOME ABNORMALITIES Complete
2006 R21 RFA-CA-06-003 FERRARI, MAURO UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON NANOPARTICLES FOR HARVESTING AND TARGETING ANGIOGENIC PROTEINS Complete
2009 R21 RFA-CA-08-006 MAKRIGIORGOS, G. MIKE DANA-FARBER CANCER INST TECHNOLOGY FOR SENSITIVE AND RELIABLE MUTATIONAL PROFILING IN PANCREATIC CANCER Complete
2012 R21 RFA-CA-12-002 CARTEGNI, LUCA SLOAN-KETTERING INST CAN RESEARCH CONTROLLED PREMATURE TERMINATION OF TRANSLATION TO GENERATE DESIGNATED TRUNCATED Complete
2016 R21 RFA-CA-15-002 CHANG, HSUEH-CHIA UNIVERSITY OF NOTRE DAME A SOLID-STATE NANOPORE MIRNA QUANTIFICATION TECHNOLOGY Complete
2012 R21 RFA-CA-12-004 JANZEN, WILLIAM PERRY UNIV OF NORTH CAROLINA CHAPEL HILL CAVITATION ENHANCEMENT OF BIOSPECIMEN PROCESSING FOR IMPROVED DNA FRAGMENTATION Complete
2016 R21 RFA-CA-15-002 GAMCSIK, MICHAEL NORTH CAROLINA STATE UNIVERSITY RALEIGH HIGH-THROUGHPUT SCREENING UNDER STATIC OR DYNAMIC HYPOXIA Complete
2019 R33 RFA-CA-18-003 CHEN, SIDI YALE UNIVERSITY Rapidly scalable platforms for direct in vivo screening of functional drivers in lethal cancers Complete
2000 R21 PAR-99-100 FU, XIANG-DONG UNIVERSITY OF CALIFORNIA SAN DIEGO CANCER CLASSIFICATION BASED ON MRNA ISOFORMS Complete
2002 R33 PAR-01-104 LI, HONGHUA UNIV OF MED/DENT NJ-R W JOHNSON MED SCH A GENETIC APPROACH TO GENOME-SCALE ANALYSIS OF CANCERS Complete
2005 R21 RFA-CA-05-003 KANDEL, EUGENE S CLEVELAND CLINIC LERNER COL/MED-CWRU REVERSIBLE PROMOTER-INSERTION FOR IN VIVO STUDIES OF MELANOMA Complete
2008 R21 RFA-CA-07-035 BARBAS, CARLOS F SCRIPPS RESEARCH INSTITUTE ZINC FINGER RECOMBINASES FOR ENDOGENOUS GENOME TAILORING Complete
2011 R21 RFA-CA-10-005 SANTANGELO, PHILIP J GEORGIA INSTITUTE OF TECHNOLOGY CHARACTERIZING GENE REGULATION WITH SINGLE MOLECULE SENSITIVE PROBES Complete
2015 R21 RFA-CA-14-005 SOHN, LYDIA L UNIVERSITY OF CALIFORNIA BERKELEY ISOLATING CIRCULATING TUMOR CELLS Complete
2018 R33 RFA-CA-17-011 SALIPANTE, STEPHEN J UNIVERSITY OF WASHINGTON Advanced development and validation of genome-scale molecular diagnostics for microsatelliteinstability using targeted molecular counting methods Complete
1999 R43 PAR-98-066 OLINER, JONATHAN D AFFYMETRIX, INC. REVERSE-ENGINEERING SIGNAL TRANSDUCTION NETWORKS Complete

Pages